Error: Could not add to watchlist. X

UBS Lux Equity Fund - Biotech USD

+ Watchlist
UBFC:TH
Tradegate
532.43
EUR
0.00
0.00%
As of 11:42:52 ET on 08/27/2015.
Previous Close
532.43
52Wk Range
354.05 - 652.78
1 Yr Return
38.20%
YTD Return
15.03%
Volume
64
Previous Close
532.43
52Wk Range
354.05 - 652.78
1 Yr Return
38.20%
YTD Return
15.03%
NAV (on -)
0
Total Assets (b USD) (on 08/27/2015)
1.599
Inception Date
10/15/1996
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
NATHALIE LOTSCHER PETRUS / SARAH COTTER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.08%
3 Mo Return
-11.40%
3 Yr Return
38.22%
5 Yr Return
-
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 404.73 k 163.49 m 9.47
Gilead Sciences Inc 1.38 m 162.01 m 9.38
Amgen Inc 893.93 k 137.24 m 7.95
Celgene Corp 952.72 k 110.26 m 6.39
BioMarin Pharmaceutical Inc 749.21 k 102.48 m 5.94
Vertex Pharmaceuticals Inc 670.02 k 82.73 m 4.79
Alexion Pharmaceuticals Inc 447.60 k 80.91 m 4.69
Regeneron Pharmaceuticals Inc 155.98 k 79.57 m 4.61
Incyte Corp 683.40 k 71.22 m 4.12
Alkermes PLC 986.49 k 63.47 m 3.68
Profile
UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.
ADDRESS
UBS Equity Fund Management Company
33A avenue J.F. Kennedy
L-1855 Luxembourg
Luxembourg
PHONE
352-44-10-10-1 Tel